Table 3. Basic clinical and demographic data of a subgroup of the lifestyle intervention study cohort separated by CHeK alterations during study course (data from T0).
| Parameter | CHeK decrease | CHeK increase |
|---|---|---|
| N | 23 | 15 |
| Female / male | 15 / 8 (65% / 35%) | 12 / 3 (80% / 20%) |
| Age | 42.0 ± 11.0 y | 42.3 ± 11.0 y |
| BMI | 42.5 ± 6.9 kg/m2 | 40.9 ± 5.6 kg/m2 |
| ALT | 34.4 ± 17.8 U/l | 30.8 ± 20.8 |
| AST | 26.4 ± 7.7 U/l | 25.3 ± 14.1 |
| GGT | 45.5 ± 59.0 U/l | 27.2 ± 16.2 U/l |
| HbA1c | 5.6 ± 0.8 | 5.7 ± 0.6 |
| HDL | 54.0 ± 13.5 | 50.7 ± 16.2 |
| LDL | 128.2 ± 43.4 | 126.5 ± 36.6 |
| Adiponectin | 6.4 ± 4.9 | 8.0 ± 4.8 |
| M30 | 243.8 ± 271.2 U/l | 165.3 ± 91.9 |
| CHeK | 3.9 (-2.9–21.4) | 0.8 (-3.8–6.8)* |
| Presence of steatosis in ultrasound | 18 (78%) | 13 (87%) |
*: p vs. patients with CHeK decrease < 0.05